Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0QSYFV)
| ADC Name |
HER2-25
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
HER2-25
Click to Show/Hide
|
|||||
| Organization |
Merck & Co. Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Tolllike receptor 7/8 agonist 18
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Direct preparation of site-specific ADC with purified antibodies in culture medium.
|
|||||